Latest News

The proposed NSRL for 4-MEI has been changed from 16 to to 29 micrograms per day.

The Office of Environmental Health Hazard Assessment (OEHHA) is providing a notice of changes made to the proposed regulation: Title 22, California Code of Regulations, sections 69401 through 69407. OEHHA has reviewed the comments it received in this second comment period and is now proposing amendments to the modified proposed regulation and is augmenting the administrative record.  A copy of the text of the amended proposed regulation is attached.

Comment period for the Changed Notice of Proposed Rulemaking Specific Regulatory Levels Posing No Significant Risk: 4-Methylimidazole (4-MEI).

A notice to establish a specific regulatory level posing no significant risk for imazalil was posted on the OEHHA website and published in the CRNR on September 9, 2011. OEHHA is withdrawing that notice because a number of non-substantive, clarifying changes to the notice were required.

Proposal to add a NSRL for imazalil of 11ug/day.

Notice to propose establishment of a specific regulatory level posing no significant risk for imazalil and amend Title 27, California Code of Regulations, section 25705.

OEHHA received the following comments after OEHHA provided notice on July 29, 2011 of modification of text of proposed regulation - Title 22, California Code of Regulations, Sections 69401 Through 69406 - Green Chemistry Toxics Information Clearinghouse Identification of Hazard Traits, Endpoints and Other Relevant Data for Inclusion in the Toxics Information Clearinghouse.

Proposal to amend Section 25707, which would remove the reference to hexavalent chromium in Section 25707(b)(4) as posing no significant risk when ingested, based on recent scientific findings that establish that chromium (hexavalent compounds) can be carcinogenic by the oral route.

Intent to list chemicals by the labor code mechanism: Estrogen–progestogen (combined) used as menopausal therapy, etoposide, etoposide in combination with cisplatin and bleomycin, methyl isobutyl ketone, MOPP (vincristine-prednisone-nitrogen mustard-procarbazine mixture).

This amendment would remove the reference to hexavalent chromium in Section 25707(b)(4) as posing no significant risk when ingested, based on recent scientific findings that establish that chromium (hexavalent compounds) can be carcinogenic by the oral route.